Fulgent Genetics (FLGT) Leases (2019 - 2025)
Fulgent Genetics (FLGT) has disclosed Leases for 7 consecutive years, with $5.0 million as the latest value for Q4 2025.
- Quarterly Leases fell 8.04% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, down 8.04% year-over-year, with the annual reading at $5.0 million for FY2025, 8.04% down from the prior year.
- Leases hit $5.0 million in Q4 2025 for Fulgent Genetics, roughly flat from $5.0 million in the prior quarter.
- In the past five years, Leases ranged from a high of $18.0 million in Q2 2022 to a low of $928000.0 in Q1 2021.
- Historically, Leases has averaged $8.1 million across 5 years, with a median of $6.9 million in 2021.
- Biggest five-year swings in Leases: surged 762.44% in 2021 and later tumbled 91.18% in 2023.
- Year by year, Leases stood at $7.1 million in 2021, then soared by 107.03% to $14.8 million in 2022, then fell by 26.69% to $10.8 million in 2023, then plummeted by 50.22% to $5.4 million in 2024, then dropped by 8.04% to $5.0 million in 2025.
- Business Quant data shows Leases for FLGT at $5.0 million in Q4 2025, $5.0 million in Q3 2025, and $4.8 million in Q2 2025.